JP2013520990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013520990A5 JP2013520990A5 JP2012556068A JP2012556068A JP2013520990A5 JP 2013520990 A5 JP2013520990 A5 JP 2013520990A5 JP 2012556068 A JP2012556068 A JP 2012556068A JP 2012556068 A JP2012556068 A JP 2012556068A JP 2013520990 A5 JP2013520990 A5 JP 2013520990A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody fragment
- mab
- seq
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 11
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 11
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 7
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 241000282324 Felis Species 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 241000282465 Canis Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 102000013135 CD52 Antigen Human genes 0.000 claims 1
- 108010065524 CD52 Antigen Proteins 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31044010P | 2010-03-04 | 2010-03-04 | |
| US61/310,440 | 2010-03-04 | ||
| PCT/US2011/000415 WO2011109108A1 (en) | 2010-03-04 | 2011-03-04 | Monoclonal antibodies directed to cd20 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016068492A Division JP2016179978A (ja) | 2010-03-04 | 2016-03-30 | Ｃｄ２０に対するモノクローナル抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013520990A JP2013520990A (ja) | 2013-06-10 |
| JP2013520990A5 true JP2013520990A5 (https=) | 2014-04-17 |
| JP5911813B2 JP5911813B2 (ja) | 2016-04-27 |
Family
ID=44542488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556068A Expired - Fee Related JP5911813B2 (ja) | 2010-03-04 | 2011-03-04 | Ｃｄ２０に対するモノクローナル抗体 |
| JP2016068492A Pending JP2016179978A (ja) | 2010-03-04 | 2016-03-30 | Ｃｄ２０に対するモノクローナル抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016068492A Pending JP2016179978A (ja) | 2010-03-04 | 2016-03-30 | Ｃｄ２０に対するモノクローナル抗体 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2542262A4 (https=) |
| JP (2) | JP5911813B2 (https=) |
| AU (2) | AU2011221553B2 (https=) |
| BR (1) | BR112012022338A2 (https=) |
| CA (1) | CA2791560A1 (https=) |
| WO (1) | WO2011109108A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2411050A4 (en) | 2009-03-25 | 2013-07-17 | Vet Therapeutics Inc | ANTIBODY REGIONS WITH A CONSTANT DOMAIN AND THEIR USE |
| EP2542258A4 (en) | 2010-03-04 | 2013-08-21 | Vet Therapeutics Inc | ON CD52 MONOCLONAL ANTIBODIES |
| ES2704007T3 (es) * | 2011-05-06 | 2019-03-13 | Nexvet Australia Pty Ltd | Anticuerpos anti-factor de crecimiento nervioso y procedimientos de preparación y uso de los mismos |
| AU2012328819B2 (en) * | 2011-10-26 | 2017-08-03 | Elanco Tiergesundheit Ag | Monoclonal antibodies and methods of use |
| KR102131544B1 (ko) | 2016-02-18 | 2020-07-07 | 엘랑코 유에스 인코포레이티드 | 키메라 개 항-cd20 항체 |
| JP2019026625A (ja) * | 2017-08-03 | 2019-02-21 | 日本全薬工業株式会社 | 抗イヌｃｄ２０モノクローナル抗体 |
| JP2021059499A (ja) * | 2019-10-03 | 2021-04-15 | 日本全薬工業株式会社 | イヌｃｄ２０に対するモノクローナル抗体又は抗体フラグメント |
| EP4656205A1 (en) | 2023-01-25 | 2025-12-03 | Nippon Zenyaku Kogyo Co., Ltd. | Method for treating canine b cell lymphoma |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JP3919830B2 (ja) * | 1992-11-28 | 2007-05-30 | 財団法人化学及血清療法研究所 | 抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片 |
| JP3087696B2 (ja) | 1997-07-25 | 2000-09-11 | 日本電気株式会社 | 分散メモリ型マルチプロセッサ・システム制御方法およびコンピュータ読み取り可能な記録媒体 |
| EP1246607B1 (en) | 1999-12-30 | 2007-06-27 | Dana-Farber Cancer Institute, Inc. | Proteoliposomes containing an integral membrane protein having one or more transmembrane domains |
| US7261890B2 (en) * | 2001-12-21 | 2007-08-28 | Idexx Laboratories, Inc. | Methods for using canine immunoglobulin variable domains and caninized antibodies |
| WO2003068821A2 (en) * | 2002-02-14 | 2003-08-21 | Immunomedics, Inc. | Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| ZA200503075B (en) * | 2002-11-07 | 2006-09-27 | Immunogen Inc | Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| US20080299546A1 (en) * | 2004-02-10 | 2008-12-04 | Nihon University | Canine Cd20 Gene |
| US7531628B2 (en) * | 2004-05-28 | 2009-05-12 | Idexx Laboratories, Inc. | Canine CD20 compositions |
| GB0707640D0 (en) | 2007-04-20 | 2007-05-30 | Strathclyde | Acoustic deterrence |
| EP2331579B1 (en) | 2008-09-04 | 2017-07-05 | Vet Therapeutics, Inc. | Monoclonal antibodies |
-
2011
- 2011-03-04 WO PCT/US2011/000415 patent/WO2011109108A1/en not_active Ceased
- 2011-03-04 AU AU2011221553A patent/AU2011221553B2/en not_active Ceased
- 2011-03-04 CA CA2791560A patent/CA2791560A1/en not_active Abandoned
- 2011-03-04 JP JP2012556068A patent/JP5911813B2/ja not_active Expired - Fee Related
- 2011-03-04 EP EP11751028.9A patent/EP2542262A4/en not_active Withdrawn
- 2011-03-04 BR BR112012022338A patent/BR112012022338A2/pt not_active IP Right Cessation
-
2016
- 2016-03-30 JP JP2016068492A patent/JP2016179978A/ja active Pending
- 2016-08-19 AU AU2016216710A patent/AU2016216710A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013520999A5 (https=) | ||
| JP2013520990A5 (https=) | ||
| CY1123791T1 (el) | Μονοκλωνικο αντισωμα ιντερλευκινης-31 | |
| DOP2013000129A (es) | PROTEÍNAS DE UNIÓN AL TNF-a. | |
| NZ588713A (en) | Antibodies to receptor of advanced glycation end products (rage) and uses thereof | |
| BR112012007365A2 (pt) | proteínas de ligação à il-1 | |
| SG194466A1 (en) | Non-human animals expressing antibodies having a common light chain | |
| WO2011050106A3 (en) | Anti-cd3 antibody dosing in autoimmune disease | |
| CY1119994T1 (el) | Συνθεσεις και μεθοδοι για αυξηση της μυϊκης μαζας και της μυϊκης δυναμης ανταγωνιζοντας ειδικα ton gdf8 και/ή την ακτιβινη α | |
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2014503189A5 (https=) | ||
| UA115439C2 (uk) | Гуманізоване антитіло, яке розпізнає альфа-синуклеїн | |
| UA116194C2 (uk) | Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном | |
| PE20180249A1 (es) | Anticuerpos neutralizadores anti-ccl20 | |
| MX2012004084A (es) | Anticuerpos siglec-15 para tratar enfermedad relacionada con perdida osea. | |
| MX2015012540A (es) | Ratón de cadena ligera común. | |
| AR077594A1 (es) | Anticuerpos completamente humanos para btla (atenuante de linfocitos b y t) | |
| BRPI0821682A2 (pt) | Anticorpo monoclonal ou uma sua porção ligante de antígeno, composição farmacêutica, métodos para tratar uma doença imunológica e para produzir o anticorpo monoclonal ou sua porção ligante de antígeno, linhagem de célula isolada, molécula de ácido nucleico isolada, vetor, célula hospedeira, e, processo para identificar anticorpos anti-mif. | |
| JP2014061000A5 (https=) | ||
| MX379533B (es) | Ratones de cadena ligera universal humanizados. | |
| MX353278B (es) | Raton con cadena ligera comun. | |
| IL198379A (en) | Human antibodies and antibodies that bind sphingosine-1-phosphate, their encoded nucleic acids, and their preparations and methods for treating the disease | |
| NZ602892A (en) | Antibodies that bind human cd27 and uses thereof | |
| CL2007003479A1 (es) | Anticuerpo monoclonal humano anti-cd22 o un fragmento de union a antigeno del mismo; acido nucleico, vector, celula huesped; método de preparacion; composicion; inmunoconjugado; y su uso para inhibir el crecimiento de un tumor o tratar un desorden inflamatorio o autoinmune en un sujeto. | |
| JP2013538057A5 (https=) |